Small Cap Feast
Small Cap Feast – 24/03/2021
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
PensionBee, the online pensions provider, with a mission to make pensions simple, so that everyone can look forward to a happy retirement, considering an IPO on the High Growth Segment of the Main Market of the London Stock Exchange. PensionBee is a leading online pensions provider in the UK, with approximately 130,000 Active Customers and £1.5 billion of assets under administration , in each case as at 28 February 2020.
Cornerstone FS to join AIM, an SME focused, cloud-based provider of international payment, currency risk management and electronic account services focused on removing the complexity of international payments for customers. Raising £2.2m. Mkt Cap £12.3m. Due 6 April.
Imperial X (AQSE:IMPP) to join the Main Market (standard). It is also proposed that on Admission to the Official List, the Company will change its name to Cloudbreak Discovery Plc. With effect from Admission, Imperial X will hold equity positions and royalties in a variety of projects in the natural resources sector across multiple jurisdictions, primarily in the Americas and Africa. The Company is proposing to raise up to £1.5m by way of placing of new Ordinary Shares to support further prospect acquisitions. Current Mkt cap £4.7m Expected April 2021.
Parsley Box, the direct to consumer provider of ready meals to the 60+ demographic, recently announced its AIM IPO plans. Parsley Box provides ready meals, which are not required to be stored in a fridge or freezer, have a shelf life of up to six months and are cooked in minutes. The company reported revenue of £24.4m for the financial year ended 31 December 2020 (unaudited). Deal details TBC and admission is expected to occur late March/ early April 2021.
ActiveOps, a UK-based leader in Management Process Automation (MPA), providing a SaaS platform to large enterprises with complex and often global back-offices is planning to join AIM. Details TBA. Due late March.
Proposed move to AIM from the main market (standard) by Emmerson (EML.L) to provide Emmerson with access to a market and environment which is more suited, in the Board’s view, to the Company’s current size and strategy ahead of pivotal period for the Company with the commencement of mine construction at the Khemisset Potash Project expected by end of 2021. Follows recent award of Mining Licence granting Emmerson exclusive right to develop and mine the potash deposit and £5.5m raise to fund ongoing project development work.
NextEnergy Renewables to launch an IPO on the Main Market. NREN is a differentiated renewables investment Company that aims to capture the most attractive private renewables and energy transition infrastructure investment opportunities globally. Targeting a £300m raise. NREN is targeting total returns of 9-11 per cent. per annum (net of all fees and expenses but including the Target Dividend and capital appreciation) . The Company’s target dividend yield for the first full financial year to 31 December 2022 is 5.5 pence. Due Early March 2021.
Digital 9 Infrastructure launch an initial public offering on the Specialist Fund Segment of the Main Market of the London Stock Exchange, by way of an initial placing and offer for subscription for a target issue £400m. Digital 9 Infrastructure plc is a newly established, externally managed investment trust. The Company will invest in a range of digital infrastructure assets which deliver a reliable, functioning internet. The IPO Prospectus is expected to be published in March 2021.
Fix Price announces its intention to float on the Main Market of the London Stock Exchange. Fix Price is one of the leading variety value retailers globally and the largest in Russia, with more than 4,200 stores. Fix Price has revenues of RUB 190.1bn, RUB 142.9bn and RUB 108.7bn for 2020, 2019 and 2018, respectively. Adjusted EBITDA for the same years was RUB 36.8bn, RUB 27.2bn and RUB 14.2bn, respectively. The Offer would consist of an offering of GDRs by certain existing shareholders of the Company.
Great Point Entertainment Income Trust PLC announced its prospectus has been approved by the FCA. Great Point Entertainment Income Trust PLC is a newly established, externally managed closed-ended investment company. The Company will provide project finance to content makers and commissioners in the global television and film production industry via senior loans secured against pre-sold intellectual property (IP) rights. GPEIT’s investment objective is to provide Shareholders with dividend income and modest capital growth through exposure to media content finance.
Deliveroo has applied for admission of the Company’s Shares to the standard listing segment of the Official List of the FCA and to trading on the main market of the London Stock Exchange. Deliveroo works with over 115,000 best loved restaurants, takeaways and grocery stores globally and provide work to over 100,000 riders across 800 locations in 12 markets, serving 6m customers globally. The price range for the Offer has been set at £3.90 to £4.60 per Share, implying an estimated market capitalization at Admission of between £7.6 billion and £8.8 billion. Raising c. £1bn. Due 7 April
ADM Energy* 4.15p £5.1m (ADME.L)
The natural resources investing company, announced the successful completion of its Fundraising which has now closed oversubscribed. The offer was enlarged to accommodate additional investor interest from both new and existing investors.
The Placing and Subscription Offer has raised approximately £1,220,000 (before commission and expenses) through the placing and subscription of 28,710,250 new Ordinary Shares at an Issue Price of 4.25 pence per share. Certain directors, PDMRs and other investors participated in the Subscription.
As previously disclosed, the purpose of the Subscription and Placing is, inter alia, to fund the acquisition of a 51% interest in Karra Oil Noble Hill, and through that a controlling interest in a Risk Sharing Agreement for the development of the large-scale Barracuda Field in OML 141, an existing discovery and near-term production asset in swamp/shallow waters offshore Nigeria.
Aquis Exchange 580p £158m (AQX.L)
A survey undertaken by Aquis Stock Exchange (AQSE) and ShareSoc has shown that individual investors do not feel they have good, equal access to growth stocks.
Key findings of the survey
· 55% of individual investors polled feel they don’t have, or aren’t sure they have, good access to growth companies · Around 50% of respondents commented that they do not believe that they have enough access to IPOs and fundraises · Individual investors are frustrated about the privileged access afforded to institutional investors, often at discounted prices · Over 80% of respondents feel individual investors should be able to trade shares in any public company they choose, irrespective of the exchange it is on.
The survey showed that most individual investors are not taking up the trading opportunities available on AQSE. AQSE is a home to growth companies and is dedicated to providing better access to SME stocks for individual investors.
On the Apex segment of AQSE growth market:
– Individual investors are able to immediately participate in IPOs as a growth prospectus is required – Short selling is prohibited (aside from Market Makers) – Spreads are all within 5% – the result of its previously announced innovative Market Maker scheme.
Block Commodities 0.0295p £2.17m (AQSE:BLCC)
Cannabis Seed Stock – Option Agreement—The Company and Century Cobalt Corporation, have entered into an option agreement to acquire approximately 2m seeds from a private seed bank based in Cleveland, Ohio. CCOB is a publicly traded (OTCQB: CCOB) cobalt exploration and development company headquartered in Los Angeles, California.
The seeds comprise 4 varietals suitable for the production of medicinal grade cannabis, with an average 14.5% Cannabinoid content and a 0.25% THC content. If the Option is exercised, each of BCL and CCOB will hold an interest of 50% in the cannabis seed stock.
The option is for an exclusivity period of 90 days to complete due diligence and the purchase. The proposed terms of the purchase are as follows: Payment of an Option fee of £2, to be apportioned equally between the Acquiring Parties, and Payment by BLCC of GBP 100,000 through the issue of 142,857,143 fully paid ordinary shares in BLCC (calculated at 0.07p per share) upon exercise of the option, and contemporaneously the payment by CCOB of GBP100,000 of CCOB fully paid ordinary shares in CCOB at US Cents 7 per share (using the US$:GB£ closing middle market exchange rate published by the Bloomberg on the day immediately prior to completion).
Altona Rare Earths 13p £2.4m (AQSE:ANR)
Altona has entered into a Memorandum of Understanding with Ussokoti Investimetos Limitada to start a legal and technical Due Diligence period of 90 days with a view to acquiring up to 70% in the Monte Muambe Rare Earths Project, via an earn-in arrangement. The tenement is located in Tete Province, Northwestern Mozambique, held by Ussokoti under Prospecting Licence 7573L. The licence covers a 4km diameter circular carbonatite intrusion.
The project has seen previous exploration for the mineral fluorspar, between 2010 and 2012, including 165 reverse circulation drillholes totaling over 12,000m. Drill holes intersected Rare Earth Elements (“REE”) mineralisation in at least four different zones within the intrusion, all of which are open in several directions. Additionally, only about 5% of the surface area of the intrusion have been drilled so far, thus leaving significant potential for discoveries.
Available data indicate that REE mineralisation is at least partly bastnaesite-hosted, and that individual REE intercept grades reach up to 4.1%. Three significant intercepts have been reported: 49m at 2.51% Total Rare Earths Oxide (TREO) from the surface, 36m at 2.53% TREO from the surface, and 96 m at 2.2% TREO from surface.
Hargreaves Services 324p £105m (HSP.L)
The diversified group delivering services to the industrial and property sectors announced that its specialist earthworks business, Blackwell, has been appointed by the EKFB JV to carry out earthworks on part of the HS2 project.
The appointment follows Blackwell’s 2018 engagement by the EKFB team as an advance works contractor and falls on the ninth anniversary of Blackwell’s association with the HS2 programme in a professional services capacity. The subcontract appointment is for 30km of the HS2 earthworks centred on Aylesbury in Buckinghamshire and involves the movement of nearly 15m cubic meters of chalk and clay over the next four years. The award is the largest in Blackwell’s 65 year history.
The award is a welcome addition to the Group’s steadily growing order book, adding to the six framework agreements previously announced in the first half of the financial year. The appointment demonstrates further progress in the Group’s stated plan to deliver reliable and growing profits from Distribution & Services.
Bahamas Petroleum 0.475p £23m (BPC.L)
Update on its high-impact exploration assets in The Bahamas and Uruguay.
· Since the completion of the drilling of Perseverance #1 , the Company has had discussions with industry counterparties in relation to a potential farm-out of its licences in The Bahamas, and is working to formalise an entirely new farm-out process. Consequently, the Company intends to renew the four southern licences in The Bahamas into a third, three year “drill or drop” exploration period
· Final Perseverance #1 drilling cost expected to be approx. $45m compared to pre-drill estimate of approx. $35m; additional costs of approx. $10m incurred as a result of heightened Covid-19 procedures (approx. $3m) and side-tracking operations related to mechanical debris in the well (approx. $7m)
· Formal contract execution for Off -1 block in Uruguay expected 2Q 2021; independent technical work undertaken by Uruguayan national oil company ANCAP indicates a P50 estimated ultimate recovery volume (EUR) of 1.34bn barrels at the Lenteja prospect
· Cash on hand of approx. $13m (as at 1 March 2021, including unconditionally committed convertible notes); anticipated additional capital requirement in 2021/22 across the business of $25 – $40m, the Company expects to more than cover the difference from various potential funding sources.
Titon Holdings 136.5p £15.2m (TON.L)
The international manufacturer and supplier of ventilation systems, and window and door hardware announced theappointment of Matthew Norris as Chief Executive Officer. Matthew will take up the position of CEO and join the Board on 12 July 2021.
Mat brings extensive experience from his previous roles, firstly at Ford Motor Company where he became a Program Leader and Product Development Manager and then working for Philips Electronics in their Consumer Lifestyle division, where he was Director of Manufacturing and Engineering at their site in Suffolk. Mat then worked for Johnson Matthey as General Manager at their Royston site before most recently becoming Operations Director for Jim Lawrence Lighting and Home, a manufacturer of high-end lighting and home furnishings products based in Suffolk. Mat has led innovation and delivered profitable growth and cultural change in all of his leadership roles.
Fox Marble Holdings 2.2p £8.3m (FOX.L)
The company focused on marble quarrying and processing in Kosovo and the Balkans has signed its fourth contract in less than a year to supply a major municipal construction project in Kosovo. The contract, valued in excess of EUR190,000, is to deliver cut and finished paving tiles for installation in the first stage of the redevelopment of the town square in Kamenica, eastern Kosovo.
The 6,500sq metres of cut and finished paving tiles will be supplied over the course of 2021 using material from Fox Marble’s quarries processed in its factory in Lipjan, Kosovo. This contract has been entered into with the developers charged with restoring the town square, which will be paved with material exclusively supplied by Fox Marble.
Feedback 1.325p £14.14m (FDBK.L)
The specialist medical imaging technology company, has been awarded a one year contract with a value of £84,000 with the Royal Berkshire NHS Foundation Trust for Bleepa, its flagship clinical communications platform, across a number of targeted clinical settings. The contract funding has been drawn down from the NHSx National Clinical Communication Tool Framework.
Novacyt 746p £527m (NCYT.L)
The international specialist in clinical diagnostics, announces that, further to the announcement on 2 February 2021, the Company will launch SNPsig® VariPLEXTM this week as a CE-Mark approved polymerase chain reaction (PCR) assay panel able to detect the four COVID-19 variants of concern (VOC) that are currently recognised and the two most biologically significant mutations in a single kit.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.